Sun Pharma revises offer to buy outstanding shares of Taro Pharma; stock falls
Sun proposes to acquire outstanding shares of Taro’s at $43 apiece, up from $38 per share earlier
Sun proposes to acquire outstanding shares of Taro’s at $43 apiece, up from $38 per share earlier